Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William R Short

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
The Journal of Clinical Investigation|November 17, 2021
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumoniaKatharine J Bar, Pamela A Shaw, Grace H Choi, et al.
The New England Journal of Medicine|May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final ReportJohn H Beigel, Kay M Tomashek, Lori E Dodd, et al.
Open Forum Infectious Diseases|June 29, 2023
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test CaseAna M Ortega-Villa, Noreen A Hynes, Corri B Levine, et al.
Annals of Internal Medicine|November 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment TrialGail E Potter, Tyler Bonnett, Kevin Rubenstein, et al.
The Lancet. HIV|August 7, 2025
Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi processChloe Orkin, Amy Paterson, Alexa Elias, et al.
The Lancet. Respiratory Medicine|May 26, 2022
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trialCameron R Wolfe, Kay M Tomashek, Thomas F Patterson, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
The Journal of Clinical Investigation|November 17, 2021
A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumoniaKatharine J Bar, Pamela A Shaw, Grace H Choi, et al.
The New England Journal of Medicine|May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final ReportJohn H Beigel, Kay M Tomashek, Lori E Dodd, et al.
Open Forum Infectious Diseases|June 29, 2023
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test CaseAna M Ortega-Villa, Noreen A Hynes, Corri B Levine, et al.
Annals of Internal Medicine|November 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment TrialGail E Potter, Tyler Bonnett, Kevin Rubenstein, et al.
The Lancet. HIV|August 7, 2025
Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi processChloe Orkin, Amy Paterson, Alexa Elias, et al.
The Lancet. Respiratory Medicine|May 26, 2022
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trialCameron R Wolfe, Kay M Tomashek, Thomas F Patterson, et al.
Pageof 6